Cleared Traditional

K141073 - LIQUICHEK TUMOR MARKER CONTROL

K141073 is an FDA 510(k) clearance for LIQUICHEK TUMOR MARKER CONTROL, manufactured by Bio-Rad Laboratories. The device is a Class 1 Immunology device with product code JJY cleared through the Traditional 510(k) pathway after a 59-day FDA review.

K141073 · Bio-Rad Laboratories · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2014
Decision
59d
Days
Class 1
Risk

K141073 is an FDA 510(k) clearance for the LIQUICHEK TUMOR MARKER CONTROL. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Bio-Rad Laboratories (Irvine, US). The FDA issued a Cleared decision on June 23, 2014 after a review of 59 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bio-Rad Laboratories devices

FDA 510(k) Submission Details - K141073

510(k) Number K141073 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 25, 2014
Decision Date June 23, 2014
Days to Decision 59 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
46d faster than avg
Panel avg: 105d · This submission: 59d
Pathway characteristics
Predicate-based equivalence.

JJY Device Classification - Class 1, General Controls

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 584
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K141073.
LIQUID ASSAYED CHEMISTRY CONTROL PREMIUM PLUS LEVEL 1,2 AND LEVEL 3.
K140971 · Randox Laboratories Limited · Dec 2014
Audit MicroControls Linearity LQ Special Diabetes
K142978 · Aalto Scientific, Ltd. · Nov 2014
ABX PENTRA MICRO ALB CONTROL L/H
K133676 · HORIBA ABX SAS · Jul 2014
RANDOX IMMUNOASSAY PREMIUM PLUS CONTROL LEVELS 1,2 AND LEVEL 3 AND IMMUNOASSAY PREMIUM PLUS TRI-LEVEL CONTROL
K140522 · Randox Laboratories Limited · May 2014
LIQUICHEK CARDIAC TROPONINS CONTROL, LEVELS 1,2 AND 3, TRILEVEL/MINIPAK
K140916 · Bio-Rad Laboratories · May 2014
LIQUICHEK IMMUNOLOGYCONTROL-LEVEL 1,LEVEL 2, LEVEL 3, MINIPAK
K140764 · Bio-Rad Laboratories · Apr 2014